StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology cash

Cash and short-term investments held at the end of each period.

MAIA Biotechnology's cash was $0 at Jun 30, 2026. For fiscal 2025 it was $0. The highest annual figure on record is $10.95M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2023Dec 31, 2023$7.15M-34.7%
FY2022Dec 31, 2022$10.95M+3.6%
FY2021Dec 31, 2021$10.57M+1493.8%
FY2020Dec 31, 2020$663.46K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$0-100.0%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$8.27M+9.0%
Q4 FY2023Dec 31, 2023$7.15M-34.7%
Q3 FY2023Sep 30, 2023$6.10M-56.6%
Q2 FY2023Jun 30, 2023$9.15M+12.2%
Q1 FY2023Mar 31, 2023$7.59M-26.3%
Q4 FY2022Dec 31, 2022$10.95M+3.6%
Q3 FY2022Sep 30, 2022$14.06M+28.4%
Q2 FY2022Jun 30, 2022$8.15M+20.2%
Q1 FY2022Mar 31, 2022$10.29M+1451.5%
Q4 FY2021Dec 31, 2021$10.57M–
Q3 FY2021Sep 30, 2021$10.95M–
Q2 FY2021Jun 30, 2021$6.78M–
Q4 FY2020Dec 31, 2020$663.46K–

More MAIA Biotechnology figures

See a number that looks wrong?